In girls with developmental disabilities, menstrual management should follow the same ethical and clinical principles as for other adolescents, emphasizing least invasive, reversible options and respect for future autonomy. Menstrual suppression may be appropriate to assist with hygiene and quality of life; however, hormonal methods are generally initiated after the onset of menarche to confirm pubertal development and exclude underlying endocrine disorders. Therefore, extended progestin-only therapy (e.g., depot medroxyprogesterone acetate) should not be started before menses begin. Hysterectomy is inappropriate as first-line management due to its irreversible nature, surgical risks, and significant ethical concerns regarding sterilization. Continuous combined oral contraceptives are not contraindicated and are commonly used for therapeutic amenorrhea. Evidence does not show consistent worsening of behavioural symptoms with appropriate hormonal suppression. Girls with developmental disabilities typically experience normal pubertal progression. MCCQE objectives emphasize patient-centered care, least restrictive interventions, ethical considerations in consent and capacity, and appropriate menstrual management strategies in adolescents with special needs.